Trial NCT04762160

View at ClinicalTrials.gov 
Aliases: NCT04590820
Org. Study IDs: EZH-1401

Last trial update was posted on 2024-03-25

MeSH Interventions

Rituximab

MeSH Conditions

Lymphoma Lymphoma, Follicular

Other Conditions

Follicular Lymphoma

Stopping Reasons

Decision to terminate EZH-1401 was solely due to company business decision.

Limitations And Caveats

The study was terminated early due to business reasons prior to enrolling the target number of participants needed to achieve target power and was insufficient to produce statistically reliable results and was not due to any safety concerns. No summary statistics are available given the limited data from the small number of evaluable participants and individual participant data are also not presented to protect the privacy of the individuals.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID